Yes, lowest deals start at an up front payment of US$40m with milestone payments afterwards can be upwards to $1b.
Thats an upfront payment equivalent to 11c/ share . As I said yesterday I’m expecting at least 12-15c rise in sp given the milestone payments on top and the pipeline of other opportunities. Probably going to be looking at a AU$80m plus Market Cap minimum on US$40m upfront. But this is looking to be a very safe and effective drug. The offer could be like the one that Syndax received and be almost 4 times that up front.
He also mentioned conversation is well advanced with suitable partners. Games will be played with shares next few weeks for accumulation . But with more than one major Biotech looking at this you would think offers should come in quickly.
1AD Price at posting:
2.9¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)